Diversity Investment Group
Minutes of the meeting: June 2, 1999

In Attendance: Larry Corse, Steve Shockley, Michael Wall, John Brock, Andy 
Bain, David Brodeur, David Robinson, Roger Drury, Tom Saunders, Gary 
Kaupman, Russ Douglas, David Jones, Randy Wilbur, Ron Kozak

Absent: Todd Fibus, Peter Carnel, Holly Deveny

Minutes accepted from last month's meeting.

Larry will be Assistant Secretary.

Tom will canvass for assistant treasurer.

David B. offered to teach a class at his house on completing an SSG via 
pencil and paper. Steve expressed an interest. David will send out a 
message to confirm date and time.

David B. reviewed several upcoming classes on the SSG taught by NAIC. See 
NAIC website for details (www.better-investing.org).

Members approved to reimburse David B. for $42.00 enrollment for new members 
for Better Investing magazine. (David sent money in advance.)

VP Corner:
Next Month's presentations:
David B. and Steve S.; David R.; Gary; Roger
Roger will also see if /who may want to do the "Stock to Study" for 
June.

David B. gave a report on Mariott:
Current price of $36.65 is in the HOLD zone.
Buy up to $33.17
Mariott has large investment in senior living arrangements
3% of expenses have gone toward senior living and Y2K preparedness.
Large investment in time shares. Purchased ExecuStay corporate housing.

Tom gave an update on ADP.
Current price of $40.63 is a HOLD.
Buy up to $33.46

Randy gave a presentation on Dana Corporation.
Supplier of parts for equipment makers and truck parts.
Current price of $33.32 is a BUY.
Buy up to $61.04.
Randy advised he has not had a chance to fully review the data for this SSG.

David B. made a suggestion for helping prepare for SSG presentations:
Contact the company's Investor Relations dept. and ask for last three annual 
reports to get an understanding of the company prior to doing your SSG. Can 
get this info online sometimes as well.

Andy B. gave a presentation on several generic pharmaceuticals:
Jones Pharma, Barr Labs, Teva, Mylan Labs, Watson Inc.
Barr Labs looks better by comparison but Watson was close behind. Mylan 
pays a dividend.
Problem with Barr: directors/owners own half of company.
Barr and Watson: Analysts mostly Strong Buy.
After much discussion, DIG members concluded that Watson seemed to be the 
strongest of the generic pharm stocks.

David B. gave a presentation on Robert Half.
Due to lower than expected earnings (but great earnings!) price is down.
Has the potential to triple your investment in next 5 years.
Stronger than many/most of its competitors.

David B. gave a brief presentation on why we should SELL Ionics. Members 
approved to sell Ionics.which would generate aprox. $3,400 to invest.

Tom advised that he received checks from everyone.

BUYS for tonight:
Clayton Homes, Robert Half, Watson.

Motion by Gary to buy $2,000 of Robert Half and hold the rest until next 
month was approved by the club.

Next meeting: July 7, 1999.

Minutes submitted by: David Robinson